Immune checkpoint molecules, such as programmed cell death protein-1 (PD-1) on T cells and programmed cell death ligand-1 (PD-L1) on antigen-presenting or cancer cells, play an important role in tumor surveillance, and targeting these molecules with monoclonal antibodies leads to increased T cell activation [35,36]. This evidence concerns the gene CD274 and neoplasm.